Rising Demand For Precision Medicine Propels The Growth Of Lab Automation In Drug Discovery Market: Critical Driver Shaping the Lab Automation In Drug Discovery Market in 2025

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts

Lab Automation In Drug Discovery Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
Recently, the lab automation in drug discovery market has experienced significant growth. The market, which had a value of $6.47 billion in 2024, is projected to increase to $6.81 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 5.3%. This growth during the historical period is mainly due to factors such as rising complexity in drug discovery, drive for efficiency and cost-cutting, increasing necessity for high-throughput screening, escalating labor costs, and urgency to expedite drug development timelines.

Lab Automation In Drug Discovery Market Size Forecast: What's the Projected Valuation by 2029?
The market size for lab automation in drug discovery is projected to experience robust growth in the coming years, rising to a worth of $8.4 billion by 2029, driven by a compound annual growth rate (CAGR) of 5.4%. The anticipated growth during the forecast period can be linked to sweeping drug pipelines of pharmaceutical enterprises, an upsurge in personalized medicine and precision therapeutics, an amplified focus on rare diseases and orphan drugs, the growing demand for remote and decentralized clinical trials, and the dawn of microfluidics and lab-on-a-chip technologies. The key trends during the said period to look out for include the spread of modular and customization-friendly automation solutions, the embracing of cloud-based platforms for data management and collaboration, the expansion of automation in rising markets, and the emergence of virtual drug discovery companies utilizing automation and digital technologies, along with the evolution of standardized protocols and compatible systems.

View the full report here:
https://www.thebusinessresearchcompany.com/report/lab-automation-in-drug-discovery-global-market-report

What Are the Drivers Transforming the Lab Automation In Drug Discovery Market?
The surge in demand for precision medicine, also referred to as personalized medicine, is anticipated to fuel the expansion of lab automation within the drug discovery market. This specific type of medicine is tailored to patients based on their unique genetic, environmental, and lifestyle factors. Automation in labs not only hastens research but also enhances the repeatability of experiments and efficiency of precision medicine and drug discovery processes. This, in turn, results in the production of more effective medical treatments and diagnostics that are ideal for individual patients. For example, the Personalized Medicine Coalition (PMC), a U.S.-based entity that encourages the comprehension and adoption of personalized medicine, stated in October 2022 that over 75,000 genetic testing products and 300 personalized treatments will be available for individuals suffering from various forms of cancer, rare genetic diseases, and a variety of chronic and infectious diseases. Hence, the rising demand for personalized medicine is pushing the growth of lab automation in the drug discovery market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=14410&type=smp

What Long-Term Trends Will Define the Future of the Lab Automation In Drug Discovery Market?
To gain an upper hand in the drug discovery market sphere of lab automation, major firms are intensifying their efforts towards creating innovative solutions such as rapid idea-to-data solutions. A rapid idea-to-data solution is a streamlined process or application, allowing individuals or companies to swiftly convert their concepts or ideas into practical insights or data-driven outcomes. Illustrating this, Strateos Inc., a biotech firm based in the US, unveiled a rapid idea-to-data solution specifically designed for small molecule discovery in drug development on its cloud lab automation-as-a-service platform in April 2022. The Strateos Cloud Lab Automation-as-a-Service Platform is an on-demand, expandable tool that comprises connected robotic automation with 23 workspace cells and hundreds of tools. The platform enables early lead generation through lead optimization, steered by a software design that lets users form compounds of interest in the cloud, which are then automatically put together and tested through various methods like cell-based, biochemical, and structured-activity relationship (SAR) evaluations.

Which Segments in the Lab Automation In Drug Discovery Market Offer the Most Profit Potential?
The lab automation in drug discovery market covered in this report is segmented -

1) By Type: Automated Liquid Handlers, Automated Plate Handlers, Robotic Arms, Automated Storage And Retrieval Systems, Other Types
2) By Component: Instruments, Software, Services
3) By Application: High-Throughput Screening, Compound Management, Sample Preparation, Other Applications
4) By End-User: Biotechnology And Pharmaceutical Industries, Research Institutes, Other End-Users

Subsegments:
1) By Automated Liquid Handlers: Automated Liquid Handlers, Multi-Channel Pipettes, Reagent Dispensing Systems, Automated Titrators, Liquid Handling Workstations
2) By Automated Plate Handlers: Automated Plate Handlers, Microplate Stacker Systems, Plate Transportation Systems, Plate Sorting Systems
3) By Robotic Arms: Robotic Arms, Cartesian Robots, SCARA Robots, Articulated Robots, Delta Robots
4) By Automated Storage And Retrieval Systems (ASRS): Automated Storage and Retrieval Systems (ASRS), Vertical Lift Modules (VLM), Automated Guided Vehicles (AGVs), Carousel-Based Systems, High-Density Storage Systems
5) By Other Types: Automated Sample Preparation Systems, Laboratory Information Management Systems (LIMS), Microarray Processors, Automated Screening Systems

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=14410&type=smp

Which Firms Dominate the Lab Automation In Drug Discovery Market by Market Share and Revenue in 2025?
Major companies operating in the lab automation in drug discovery market are Thermo Fisher Scientific Inc., Abbott Diagnostics, Roche Holdings Inc., Beckman Coulter, Siemens Healthineers, Becton Dickinson and Company, Agilent Technologies Inc., PerkinElmer Inc., Endress+Hauser, Shimadzu Corporation, Waters Corporation, Bio-Rad Laboratories Inc., QIAGEN, Beckhoff Automation GmbH & Co. KG, Eppendorf AG, Tecan Group Ltd., Brooks Automation Inc., Hamilton Company, AbCellera Biologics Inc., Hudson Robotics Inc., OpenTrons Labworks Inc., Quanterix Corporation, The Technology Partnership, HighRes Biosolutions Inc., Biosero Inc., Peak Analysis and Automation Ltd., Aurora Biomed Inc., Arctoris, Inveox GmbH, Synthace, Synchron Lab Automation

Which Regions Offer the Highest Growth Potential in the Lab Automation In Drug Discovery Market?
North America was the largest region in the lab automation in drug discovery market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the lab automation in drug discovery market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=14410

"This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work."

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.